Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Motor Activity 9Neoplasms 7Breast Neoplasms 6Pancreatic Neoplasms 3Malnutrition 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Prostatic Neoplasms 2Pharyngeal Neoplasms 2Obesity 2Lung Neoplasms 2Liver Neoplasms 2Diabetes Mellitus, Type 2 2Colorectal Neoplasms 2Colonic Neoplasms 2Weight Loss 1Undefined 1Stomach Neoplasms 1Skin Neoplasms 1Sarcopenia 1Rectal Neoplasms 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Mouth Neoplasms 1Lung Diseases 1Liver Diseases 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × Nutritional Status × Clear all
NCT05389332 2025-12-16

A Mobile Health Intervention Among Hispanics

Rutgers, The State University of New Jersey

Phase NA Recruiting
114 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡